Currently, at least seven in vivo melanoma phenotypes have been characterized by low to high MITF activity: undifferentiated (mesenchymal-like), neural crest stem cell-like (NCSC), interferon-active (IFN-active), starved melanoma cells (SMCs), intermediate, melanocytic, and hyper-differentiated. Here, MITF is linked to melanoma.